Drug Manufacturers Stock News
Categories
- All
- Editor's Picks
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus Research Drug Manufacturers
Hester Biosciences Ltd (BOM:524669) Q1 2025 Earnings Call Transcript Highlights: Strong Growth in Animal and Poultry Divisions Amid Overall Sales Dip
Despite a 9% overall sales decrease, Hester Biosciences Ltd (BOM:524669) reports significant growth in key divisions and a 30% profit increase for Hester India. Sep 13, 2024
GuruFocus Research Drug Manufacturers
Hester Biosciences Ltd (BOM:524669) Q4 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Strategic Advancements
Hester Biosciences Ltd (BOM:524669) reports robust financial performance with significant revenue growth and strategic debt reduction in Q4 2024. Sep 13, 2024
GuruFocus Research Drug Manufacturers
Ipca Laboratories Ltd (BOM:524494) Q1 2025 Earnings Call Transcript Highlights: Strong Domestic Growth Amid Export Challenges
Ipca Laboratories Ltd (BOM:524494) reports robust domestic formulation growth and improved market share, despite facing export and API business declines. Sep 13, 2024
GuruFocus Research Drug Manufacturers
Ipca Laboratories Ltd (BOM:524494) Q3 2024 Earnings Call Transcript Highlights: Strong Domestic Growth and Improved Margins Amid Export Challenges
Ipca Laboratories Ltd (BOM:524494) reports robust domestic performance and margin improvements, despite facing hurdles in export markets. Sep 13, 2024
GuruFocus Research Drug Manufacturers
Neuland Laboratories Ltd (BOM:524558) Q3 2024 Earnings Call Transcript Highlights: Strong Financial Performance and Strategic Investments
Neuland Laboratories Ltd (BOM:524558) reports significant growth in income and profitability, with strategic investments paving the way for future expansion. Sep 13, 2024
GuruFocus Research Drug Manufacturers
Orchid Pharma Ltd (BOM:524372) Q1 2025 Earnings Call Transcript Highlights: Robust Sales Growth and Strategic Developments
Orchid Pharma Ltd (BOM:524372) reports a 34% increase in sales and significant EBITDA growth, while navigating market challenges and expansion plans. Sep 13, 2024